Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: Zuanic | Rare Historical Photos

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Benzinga

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

Benzinga

Ayr Wellness: Analyst Reduces Price Target And Stays Neutral After Q3 Results

On Thursday, Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) reported its financial results for the third quarter that ended September 30, 2022, with revenue of $119.6 million

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results

Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) recently reported its financial results for the third quarter that ended September 30, 2022 (&ldquo

Benzinga

Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral

Acreage Holdings, Inc. (OTCQX: ACRDF) reported its financial results on Monday for the third quarter that ended September 30, 2022 (“Q3 2022”).

Benzinga

Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception

Canopy Growth Corporation (NASDAQ: CGC)

Benzinga

Green Thumb Industries' Positive Q3 Report Compels Analyst To Place It Among 'Best-Managed MSOs'

Green Thumb Industries (OTCQX: GTBIF) reported

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus

Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark.

Benzinga

Aurora & Tilray Better Positioned Than Other Cannabis Operators For Germany's Imminent Market Launch, Here's Why

A draft of the German government's cannabis legalization measure, which was leaked on Wednesday, indicates the EU country is getting close to legalizing retail distribution, possession a

Benzinga

Columbia Care: Updated Estimates Ahead Of Acquisition By Cresco Labs

The Analyst

Benzinga

Why Is Curaleaf One Of The Best-Positioned Cannabis Multi-State Operators?

Curaleaf Holdings, Inc. (OTCQX: CURLF) posted its financial results Monday for the second quarter ended June 30, 2022.

Benzinga

Analysts Going Hard On Tilray, Slashing Price Targets; How Much Adj. EBITDA Really Improved?

Tilray Brands, Inc.

Benzinga

2Q Canada Recreational Cannabis Market Analysis: +21 YoY Growth Outperforming The U.S.

In a recent analyst note, Cantor Fitzgerald's Pablo Zuanic gave an overview of the Canadian recreational cannabis market in the second quarter of 2022, according to data collected by Hifyre, a leading in-shop and online digital toolset for cannabis dispensaries.

Benzinga

Why Higher Prices Aren't Always A Bad Thing: This Analyst Explains The Canadian Cannabis Flower Market

Cannabis flower prices seem to be inversely proportional to their sales, at least according to data provided by Seattle-based Headset which tracks six recreational cannabis markets, including California, Colorado, Michigan, Nevada, Oregon and Washington state.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Curaleaf Holdings To Report Q1 Results In Anticipation Of New Jersey Legal Cannabis Launch

Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) will report its financial and operating results for the first quarter ended March 31, 2022, after market close on May 9, 2022.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Canopy Growth Corporation

46 stories

Cresco

46 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.